iHealthConnections, Volume 1 Issue 1
iHealth Connections provides a trusted platform to explore the issues and the driving forces behind this emerging trend. From strategic frameworks to decisions on managing investment and considering various scenarios for the convergence pathway, expert authors who are uniquely positioned across the sectors willprovide their perspectives on the solutions that will enable this transformation.
The inaugural issue of the journal included a superb expert opinion piece written by Rebecca Kush on ‘Transforming Medical Research with Electronic Health Records.’Furthermore, a comment piece by H Stephen Lieber offered an intuitive look into Health Technology Implementation.
Click here to access iHealthConnections – Volume 1.1
iHealthConnections, Volume 1 Issue 2
In the latest issue Charles Jaffe contributes an excellent paper, ‘Use of Patient Level Data forBiomedical Research—Path to Interoperability,’ while an interview with David B Nash offers an insightful angle on the impact of health reform. Elsewhere in this edition, Andreas Schmidt and colleaguesprovide a fascinating discussion on the EHR4CR Project – A European Survey on Electronic Health Records Systems for Clinical Research.
Click here to access iHealthConnections – Volume 1.2
Late Phase Development: Maximizing the Value of Real World Data
There is increasing recognition that data obtained under the tightly controlled settings of clinical trials do not necessarily reflect actual experience in clinical practice. At the same time, late phase development data have been recognized as important alternative information sources that reflect an uncontrolled real-world setting, complementing and expanding on clinical trial findings. Drivers for the growingimportance of late phase development data include the increasingly stringent
post-marketing regulatory environment, the move towards proactive pharmacovigilance, and the rise of comparative effectiveness research. The series of papers in this report will provide focused discussion on the challenges and benefits of late phase studies. The topics will include the major factors that must be addressed to ensure a successful late phase development strategy for novel medical interventions. The value propositions, the regulatory hurdles, and operational challenges will also be discussed with clear examples of best practices for optimization.
Click through to: Late Phase Development: Maximizing the value of real world data
To access the current edition in full and free eBook format, please click through to: Late Phase Development Ejournal
For more information please visit: www.touchhealthsciences.com
Drug Development – Volume 5
In the latest issue David M Vulcano contributes an excellent paper, ‘The ‘New Normal’ of Regulatory Oversight of Clinical Investigators,’ while Axel K Olsen and Matthew D Whalen discuss ‘A Prescription for Industry – Risk Evaluation and Mitigation Strategy and Safety as a Paradigm.’ Elsewhere in this edition, Julian C Matthews provides a fascinating exploration of Positron Emission Tomography in clinical drug development.
Directed by an Advisory Board comprising internationally respected professionals, Drug Development’s articles endeavour to provide a concise and timely update on the latest opinion and advances spanning the breadth of drug development practice.
Health Sciences Visions from Touch Briefings
‘Touch Briefings announces launch of a new eHealthcare report — Patient Management without Walls'
The articles featured in this report view the changing healthcare ecosystem—focusing on how the move toward patient-centric systems will be technology led. Data connectivity will reduce complexity, drive efficiency, and improve patient outcomes. Here, we present a series of case studies by key thought leaders and an interview from the healthcare provider perspective:
- eHealthcare—Charting the Future Healthcare Prognosis
- Healthcare Without Walls—Delivering the Future Paradigm
- Building Connectivity, Interoperability, and Communication in eHealthcare— The Healthcare Provider Perspective
- Breaking Down the Walls of Healthcare
Pharmaceutical Business Review
CDISC is pleased to collaborate with Pharmaceutical Business Review (PBR). PBR websites have all the latest news, comment and industry information. Each Business Review website offers content that is produced by a dedicated team of journalists and global industry experts.
In addition to the free content made available on the sites an intelligence store will provide you with premium market analysis reports from the leading global suppliers of market research and industry analysis.